Riccardo Giovanni Borroni

Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2− Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic Implication

R. de Sanctis, M. Gaudio, F. Jacobs, 2024, The oncologist.